# PRIME-BSPre: a genome-wide protein-RNA binding sites prediction method based on templates

**Authors:** Xinhang Wei, Yingtian Duan, Danyang Li, Xudong Liu, Juan Xie, Shiyong Liu

PMC · DOI: 10.1186/s12864-026-12657-3 · 2026-02-21

## TL;DR

PRIME-BSPre is a new method that predicts where proteins bind to RNA in the genome using RNA structure and protein data.

## Contribution

PRIME-BSPre introduces the use of low Shannon entropy to model RNA binding preferences of RBPs.

## Key findings

- PRIME-BSPre uses RNA sequence, secondary structure, and RBP tertiary structure for genome-wide predictions.
- The method includes LS-PEAK to optimize alignment screening for RNA binding site prediction.
- PRIME-BSPre shows excellent performance and robustness across different cell lines.

## Abstract

In this paper, we present PRIME-BSPre, a template-based genome-wide method for predicting protein-RNA binding sites that incorporates the RNA sequence and secondary structure as well as the tertiary structure of corresponding RBPs. We are pioneers in introducing low Shannon entropy algorithm in PRIME-BSPre to describe the binding preferences of RBPs on RNA motifs. The LS-PEAK derived from LS-Scores in PRIME-BSPre is utilized to optimize the alignments screening. PRIME-BSPre has been successfully benchmarked on the human genome, demonstrating its excellent prediction performance on independent RBP datasets and its robustness across different cell lines.

The online version contains supplementary material available at 10.1186/s12864-026-12657-3.

## Full-text entities

- **Genes:** NCBP3 (nuclear cap binding subunit 3) [NCBI Gene 55421] {aka C17orf85, ELG, HSA277841}, RTCB (RNA 2',3'-cyclic phosphate and 5'-OH ligase) [NCBI Gene 51493] {aka C22orf28, DJ149A16.6, FAAP, HSPC117, TSLIG5}, ZC3H7B (zinc finger CCCH-type containing 7B) [NCBI Gene 23264] {aka ROXAN1, RoXaN}, ZC3H8 (zinc finger CCCH-type containing 8) [NCBI Gene 84524] {aka Fliz1, ZC3HDC8}, TIAL1 (TIA1 cytotoxic granule associated RNA binding protein like 1) [NCBI Gene 7073] {aka TCBP, TIAR}, CLEC3B (C-type lectin domain family 3 member B) [NCBI Gene 7123] {aka MCDR4, TN, TNA}, ILF3 (interleukin enhancer binding factor 3) [NCBI Gene 3609] {aka CBTF, DRBF, DRBP76, MMP4, MPHOSPH4, MPP4}, CAPRIN1 (cell cycle associated protein 1) [NCBI Gene 4076] {aka CONDCAC, GPIAP1, GPIP137, GRIP137, M11S1, NEDLAAD}, BUD13 (BUD13 spliceosome associated protein) [NCBI Gene 84811] {aka ACHPS, Cwc26, fSAP71}, ALKBH5 (alkB homolog 5, RNA demethylase) [NCBI Gene 54890] {aka ABH5, OFOXD, OFOXD1}, PABPN1 (poly(A) binding protein nuclear 1) [NCBI Gene 8106] {aka OPMD, PAB2, PABII, PABP-2, PABP2}, PRPF39 (pre-mRNA processing factor 39) [NCBI Gene 55015], ATF4 (activating transcription factor 4) [NCBI Gene 468] {aka CREB-2, CREB2, TAXREB67, TXREB}
- **Species:** Saccharomyces cerevisiae (baker's yeast, species) [taxon 4932], Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** HepG2 — Homo sapiens (Human), Hepatoblastoma, Cancer cell line (CVCL_0027), HEK293 — Homo sapiens (Human), Transformed cell line (CVCL_0045), K562 — Homo sapiens (Human), Blast phase chronic myelogenous leukemia, BCR-ABL1 positive, Cancer cell line (CVCL_0004)

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13032426/full.md

---
Source: https://tomesphere.com/paper/PMC13032426